Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07775001Active, not recruiting
Randomised trial in septic shock comparing Epinephrine Group with Dopamine Group (2 arms). Primary endpoint: Shock Reversal Within 60 Minutes. Started Feb 2026; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07775001.